sulpiride has been researched along with Obsessive-Compulsive Disorder in 16 studies
Sulpiride: A dopamine D2-receptor antagonist. It has been used therapeutically as an antidepressant, antipsychotic, and as a digestive aid. (From Merck Index, 11th ed)
sulpiride : A member of the class of benzamides obtained from formal condensation between the carboxy group of 2-methoxy-5-sulfamoylbenzoic acid and the primary amino group of (1-ethylpyrrolidin-2-yl)methylamine.
Obsessive-Compulsive Disorder: An anxiety disorder characterized by recurrent, persistent obsessions or compulsions. Obsessions are the intrusive ideas, thoughts, or images that are experienced as senseless or repugnant. Compulsions are repetitive and seemingly purposeful behavior which the individual generally recognizes as senseless and from which the individual does not derive pleasure although it may provide a release from tension.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of the study was to investigate the prevalence rates of obsessive-compulsive disorder (OCD) and hypochondriasis in schizophrenic patients treated with atypical antipsychotics (AAPs) and to investigate the different comorbidity rates of OCD and hypochondriasis between clozapine-treated patients and patients treated with other AAPs." | 7.80 | Hypochondriasis and obsessive-compulsive disorder in schizophrenic patients treated with clozapine vs other atypical antipsychotics. ( Cantisani, A; Ferrari, G; Grassi, G; Pallanti, S; Poli, L; Righi, L, 2014) |
| "A 14-year-old boy with obsessive-compulsive disorder (OCD) developed, under fluvoxamine treatment, acute symptoms of Tourette's syndrome (TS) with aggravation of the OCD." | 7.69 | Emergence of symptoms of Tourette's syndrome during fluvoxamine treatment of obsessive-compulsive disorder. ( Fennig, S; Fennig, SN; Pato, M; Weitzman, A, 1994) |
| "Amisulpiride 200 mg/day was added to ongoing SRI treatment and titrated up to 600 mg/day in flexible doses." | 6.71 | Amisulpiride augmentation in treatment resistant obsessive-compulsive disorder: an open trial. ( Metin, O; Tot, S; Yazici, AE; Yazici, K, 2003) |
| "The aim of the study was to investigate the prevalence rates of obsessive-compulsive disorder (OCD) and hypochondriasis in schizophrenic patients treated with atypical antipsychotics (AAPs) and to investigate the different comorbidity rates of OCD and hypochondriasis between clozapine-treated patients and patients treated with other AAPs." | 3.80 | Hypochondriasis and obsessive-compulsive disorder in schizophrenic patients treated with clozapine vs other atypical antipsychotics. ( Cantisani, A; Ferrari, G; Grassi, G; Pallanti, S; Poli, L; Righi, L, 2014) |
| "We stratified 70 patients with schizophrenia according to their mode of antipsychotic treatment: clozapine and olanzapine (group I) compared with aripiprazole and amisulpride (group II)." | 3.77 | Antiserotonergic antipsychotics are associated with obsessive-compulsive symptoms in schizophrenia. ( Englisch, S; Esslinger, C; Meyer-Lindenberg, A; Rausch, F; Schirmbeck, F; Zink, M, 2011) |
| "A 14-year-old boy with obsessive-compulsive disorder (OCD) developed, under fluvoxamine treatment, acute symptoms of Tourette's syndrome (TS) with aggravation of the OCD." | 3.69 | Emergence of symptoms of Tourette's syndrome during fluvoxamine treatment of obsessive-compulsive disorder. ( Fennig, S; Fennig, SN; Pato, M; Weitzman, A, 1994) |
| "Amisulpiride 200 mg/day was added to ongoing SRI treatment and titrated up to 600 mg/day in flexible doses." | 2.71 | Amisulpiride augmentation in treatment resistant obsessive-compulsive disorder: an open trial. ( Metin, O; Tot, S; Yazici, AE; Yazici, K, 2003) |
| "Patients with Tourette's syndrome often develop multiple psychopathological symptoms beyond the basic symptoms (motor and vocal tics)." | 1.31 | [Disguised Tourette's syndrome. A contribution to the differential diagnosis on phobia and fear]. ( Barnett, W; Bednarz, K; Haisch, S, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (18.75) | 18.2507 |
| 2000's | 7 (43.75) | 29.6817 |
| 2010's | 6 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Naguy, A | 1 |
| Grassi, G | 1 |
| Poli, L | 1 |
| Cantisani, A | 1 |
| Righi, L | 1 |
| Ferrari, G | 1 |
| Pallanti, S | 1 |
| Mendhekar, DN | 1 |
| Schirmbeck, F | 1 |
| Esslinger, C | 1 |
| Rausch, F | 1 |
| Englisch, S | 1 |
| Meyer-Lindenberg, A | 1 |
| Zink, M | 1 |
| Ersche, KD | 2 |
| Cumming, P | 1 |
| Craig, KJ | 2 |
| Müller, U | 2 |
| Fineberg, NA | 2 |
| Bullmore, ET | 2 |
| Robbins, TW | 2 |
| Roiser, JP | 1 |
| Abbott, S | 1 |
| Suckling, J | 1 |
| Ooi, C | 1 |
| Shabbir, SS | 1 |
| Clark, L | 1 |
| Sahakian, BJ | 1 |
| Merlo-Pich, EV | 1 |
| Rickards, H | 1 |
| Cavanna, AE | 1 |
| Worrall, R | 1 |
| Bednarz, K | 1 |
| Haisch, S | 1 |
| Barnett, W | 1 |
| Metin, O | 1 |
| Yazici, K | 1 |
| Tot, S | 1 |
| Yazici, AE | 1 |
| Poyurovsky, M | 1 |
| Weizman, R | 1 |
| Weizman, A | 1 |
| Koran, L | 1 |
| Kim, SW | 1 |
| Shin, IS | 1 |
| Kim, JM | 1 |
| Yang, SJ | 1 |
| Hwang, MY | 1 |
| Yoon, JS | 1 |
| Fennig, S | 1 |
| Fennig, SN | 1 |
| Pato, M | 1 |
| Weitzman, A | 1 |
| George, MS | 1 |
| Trimble, MR | 1 |
| Sevincok, L | 1 |
| Uslu, A | 1 |
| Kaynak, H | 1 |
| Dereboy, F | 1 |
| Baving, L | 1 |
| Schmidt, MH | 1 |
| Stárková, L | 1 |
| Wiedermann, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Augment in Treatment-resistent Obsessive-compulsive Disorder: an Open-label Trial[NCT00590642] | 30 participants (Anticipated) | Observational | 2006-04-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 trials available for sulpiride and Obsessive-Compulsive Disorder
| Article | Year |
|---|---|
Response perseveration in stimulant dependence is associated with striatal dysfunction and can be ameliorated by a D(2/3) receptor agonist.
Topics: Adult; Amisulpride; Amphetamine-Related Disorders; Benzothiazoles; Brain Mapping; Cocaine-Related Di | 2011 |
Amisulpiride augmentation in treatment resistant obsessive-compulsive disorder: an open trial.
Topics: Adult; Aged; Amisulpride; Antidepressive Agents; Antipsychotic Agents; Drug Resistance; Drug Therapy | 2003 |
Dystonic reaction associated with fluvoxamine.
Topics: Adult; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Dystonia; F | 1993 |
13 other studies available for sulpiride and Obsessive-Compulsive Disorder
| Article | Year |
|---|---|
An Adult With Obsessive-Compulsive-Related Disorders and Tics Post-Carbon Monoxide Poisoning Who Responded Ultimately to Electroconvulsive Therapy.
Topics: Adult; Antipsychotic Agents; Carbon Monoxide Poisoning; Combined Modality Therapy; Electroconvulsive | 2019 |
Hypochondriasis and obsessive-compulsive disorder in schizophrenic patients treated with clozapine vs other atypical antipsychotics.
Topics: Adult; Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Comorbidity; Fem | 2014 |
Hyperpigmentation with amisulpride.
Topics: Adult; Amisulpride; Antipsychotic Agents; Chronic Disease; Drug Therapy, Combination; Female; Fluvox | 2009 |
Antiserotonergic antipsychotics are associated with obsessive-compulsive symptoms in schizophrenia.
Topics: Adult; Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Comorbidity; Fem | 2011 |
Amisulpride-induced acute akathisia in OCD: an example of dysfunctional dopamine-serotonin interactions?
Topics: Adult; Akathisia, Drug-Induced; Amisulpride; Dopamine; Female; Humans; Male; Obsessive-Compulsive Di | 2012 |
Treatment practices in Tourette syndrome: the European perspective.
Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Anxiety; Aripiprazole; Atomoxetine Hydrochloride | 2012 |
[Disguised Tourette's syndrome. A contribution to the differential diagnosis on phobia and fear].
Topics: Adult; Anxiety Disorders; Clomipramine; Clonazepam; Cognitive Behavioral Therapy; Combined Modality | 2002 |
Memantine for treatment-resistant OCD.
Topics: Adult; Clomipramine; Dopamine Antagonists; Drug Therapy, Combination; Excitatory Amino Acid Antagoni | 2005 |
Amisulpride improves obsessive-compulsive symptoms in schizophrenia patients taking atypical antipsychotics: an open-label switch study.
Topics: Adult; Amisulpride; Antipsychotic Agents; Aripiprazole; Comorbidity; Dopamine Antagonists; Dose-Resp | 2008 |
Emergence of symptoms of Tourette's syndrome during fluvoxamine treatment of obsessive-compulsive disorder.
Topics: Adolescent; Arousal; Drug Therapy, Combination; Fluvoxamine; Humans; Loxapine; Male; Neurologic Exam | 1994 |
Sulpiride addition in a case of fluvoxamine-refractory obsessive-compulsive disorder without comorbid psychopathology.
Topics: Antidepressive Agents, Second-Generation; Female; Fluvoxamine; Humans; Middle Aged; Obsessive-Compul | 2000 |
[Obsessive-compulsive disorder, frontostriatal system and the effect of the serotonergic system].
Topics: Adolescent; Behavior Therapy; Child; Clomipramine; Combined Modality Therapy; Female; Fluvoxamine; H | 2000 |
Our experience with incisive neuroleptic drugs in child psychiatry.
Topics: Antipsychotic Agents; Autistic Disorder; Child; Haloperidol; Humans; Mental Disorders; Obsessive-Com | 1991 |